Body burden of the general population with di(2-ethylhexyl)-phthalate (DEHP);Die innere belastung der allgemeinbevölkerung mit di(2-ethylhexyl)phthalat (DEHP)

Umweltmedizin in Forschung und Praxis

Volumn 8, Issue 1, 2003, Pages 15-23

  Koch, Holger Martin ^a   Drexler, Hans ^a   Angerer, Jürgen ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Biological monitoring; DEHP; Di(2 ethylhexyl)phthalate; Exposure; Phthalates; Urine

Indexed keywords

2 ETHYL 5 HYDROXYHEXYLPHTHALATE; 2 ETHYL 5 OXOHEXYLPHTHALATE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PHTHALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; BODY BURDEN; BODY WEIGHT; DRUG TOLERABILITY; ECOTOXICITY; ENVIRONMENTAL FACTOR; HEALTH HAZARD; HUMAN; MEDICAL SOCIETY; METABOLITE; POPULATION; POPULATION EXPOSURE; REVIEW; SAMPLE; TOXICITY; URINALYSIS;

EID: 0037230864     PISSN: 14308681     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Albro PW, Corbett JT, Schroeder JL, Jordan S, Matthews HB (1982a): Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environ Health Perspect 45, 19-25
2. Albro PW, Hass JR, Peck CC, Jordan ST, Corbett JT, Schroeder J (1982b): Applications of isotope differentiation for metabolic studies with di-(2-ethylhexyl) phthalate. J Environ Sci Health B 17, 701-714
3. Albro PW, Tondeur I, Marbury D, Jordan S, Schroeder J und Corbett JT (1983): Polar metabolites of di(2-ethylhexyl)phthalate in the rat. Biochim Biophys Acta 760, 283-292
4. Albro PW (1986): Absorption, metabolism, and excretion of di(2-ethylhexyl)phthalate by rats and mice. Environ Health Perspect 65, 293-298
5. Albro PW, Lavenhar SR (1989): Metabolism of di(2-ethylhexyl)-phthalate. Drug Metab Rev 21, 13-34
6. Anderson WA, Castle L, Scotter MJ, Massey RC, Springall C (2001): A biomarker approach to measuring human dietary exposure to certain phthalate diesters. Food Addit Contam 18, 1068-1074
7. Anderson WA, Barnes KA, Castle L, Damant AP, Scotter MJ (2002): Determination of isotopically labelled monoesterphthalates in urine by high performance liquid chromatography-mass spectrometry. Analyst 127, 1193-1197
8. Angerer J (1985): Biological monitoring of workers exposed to organic solvents-past and present. Scand J Work Environ Health 11 (Suppl 1), 45-52
9. Angerer J, Gündel J (1996): Biomonitoring and occupational medicine. Possibilities and limitations. Ann Ist Super Sanita 32, 199-206
10. Angerer J, Schaller KH (1998): Biological Materials, Hazardous Substances Analyses of. In: Meyers RA, Ed: Encyclopedia of Environmental Analysis and Remediation (EEAR). John Wiley & Sons, New York, S 702-731
11. Angerer J (2001): Das Biological Monitoring in der Arbeits- und Umweltmedizin - dezeitiger Stand und künftige Entwicklungen. In: DFG, Angerer J, Eds: Biological Monitoring. VCH Verlagsgesellschaft, Weinheim, S 5-15
12. Arcadi FA, Costa C, Imperatore C, Marchese A, Rapisardi A, Salemi M, et al. (1998): Oral toxicity of bis(2-ethylhexyl)phthalate during pregnancy and suckling in the Long-Evans rat. Food Chem Toxicol 35, 963-970
13. Asaoka K, Hagihara K, Kabaya H, Sakamoto Y, Katayama H, Yano K (2000): Uptake of phthalate esters, di(n-butyl)phthalate and di(2-ethylhexyl)phthalate, as environmental chemicals in monkeys in Japan. Bull Environ Contam Toxicol 64, 679-685
14. ATSDR, Agency for toxic substances and disease registry (1993): Toxicological Profile for di(2-ethylhexyl)phthalate (TP-92/05). U.S. Department of Health and Human Services
15. Blount BC, Milgram KE, Silva MJ, Malek NA, Reidy JA, Needham LL, Brock JW (2000a): Quantitative detection of eight phthalate metabolites in human urine using HPLC-APCI-MS/MS. Anal Chem 72, 4127-4134
16. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, et al. (2000b): Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 108, 972-982
17. Booker SM (2001): NTP center reports on phthalate concerns. Environ Health Perspect. 109(6), A260-1
18. Brock JW, Caudill SP, Silva MJ, Needham LL, Hilborn ED (2002): Phthalate monoester levels in the urine of young children. Bull Environ Contam Toxicol 68, 309-314
19. Bruder A, Lindner S, Mügge J, Saffert R, Spindler E (1999): PVC - der Werkstoff für Medizinprodukte. Swiss Plastics 21, 5-10
20. BUA, Beratergremium für umweltrelevante Altstoffe, Ed (1986): Di-(2-ethylhexyl)phthalat; BUA-Stoffbericht 4, VCH-Verlagsgesellschaft, Weinheim
21. BUA, Beratergremium für umweltrelevante Altstoffe, Ed (1987): Dibutylphthalat; BUA-Stoffbericht 22, VCH-Verlagsgesellschaft, Weinheim
22. BUA, Beratergremium für umweltrelevante Altstoffe, Ed (1993): BUA-Stoffbericht 114, Ergänzungsberichte I, VCH-Verlagsgesellschaft, Weinheim
23. Calafat AM (2002): persöhnliche Mitteilung
24. CDC, Centers for Disease Control and Prevention (2001): National Report on Human Exposure to Environmental Chemicals. Centers for Disease Control and Prevention and National Center for Environmental Health, Division of Laboratory Sciences. Mail Stop F-20. 4770 Buford Highway, N.E.
25. Atlanta, Georgia 30341-3724, USA
26. Colon I, Caro D, Bourdony CJ, Rosario O (2000): Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 108, 895-900
27. CSTEE, Scientific committee on toxicity, ecotoxicity and the environment (1998): Opinion on Phthalate migration from soft PVC toys and child-care articles - Data made available since the 16th of June 1998, opinion expressed at the 6th CSTEE plenary meeting, Brussels, 26/27 November 1998
28. David RM (2000): Exposure to phthalate esters. Environ Health Perspect 108, A440
29. Dirven HA, van den Broek PH, Nordkamp HH, de Lepper AJ, Henderson PT, Jongeneelen FJ (1993a): Metabolites of the plasticizer di(2-ethylhexyl)phthalate in urine samples of workers in polyvinylchloride processing industries. Int Arch Occup Environ Health 64, 549-554
30. Dirven HA, van den Broek PH, Jongeneelen FJ (1993b): Determination of four metabolites of the plasticizer di(2-ethylhexyl)phthalate in human urine samples. Int Arch Occup Environ Health 64, 555-560
31. DFG, Deutsche Forschungsgemeinschaft (2002): Di(2-ethylhexyl)phthalat (DEHP). In: H. Greim, Ed: Gesundheitsschädliche Arbeitsstoffe - Toxikologisch-arbeitsmedizinische Begründungen von MAK-Werten. 35. Ergänzungslieferung, Wiley-VCH
32. Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J, Wilkinson C, et al. (1999): A cancer risk assessment of Di(2-ethylhexyl)phthalate: Application of new U.S. EPA risk assessment guidelines. Regul Toxtoxicol Pharmacol 29, 327-357
33. Draviam EJ, Kerkay J, Pearson KH (1980): Separation and quantification of urinary phthalate metabolites by HPLC. Anal Lett 13B, 1137-1155
34. EPA, U.S. Environmental Protection Agency (1999): Integrated Risk Information System (IRIS) on Di(2-ethylhexyl)phthalate. National Center for Environmental Assessment, Office of Research and Development, Washington, DC., USA
35. EU - European Commission (2002): Opinion on medical devices containing DEHP plasticised PVC; neonates and other groups possibly at risk from DEHP toxicity. Adopted by the Scientific Committee on Medical Products and Medical Devices on 26 September 2002. Doc. SANCO/SCMPMD/2002/0010Final. Health and Consumer Protection Directorate - General
36. FDA, U.S. Food and Drug Administration (2001a): Phthalates and cosmetic products. Center for Food Safety and Applied Nutrition, Office of Cosmetics and Colors Fact Sheet, April 19, 2001, U.S. Food and Drug Administration
37. FDA, U.S. Food and Drug Administration (2001b): Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from medical devices. Center for Devices and Radiological Health, U.S. Food and Drug Administration, 12709 Twinbrook Parkway. Rockville, MD 20852, USA
38. Fromme H (1999): Organische Stoffe - Phthalate. In: Beyer, Eis, Eds: Praktische Umweltmedizin: Chemische Faktoren, Teil 4. Springer Verlag, Berlin
39. Gilsing H-D, Angerer J, Prescher D (2002): Monophthalates with oxidized C5-carbon in the ester chain: a simple synthetic access to two major metabolites of Bis-(2-ethylhexyl)-phthalate. Monatshefte für Chemie 133, 1147-1155
40. Gray Jr LE, Ostby J, Furr J, Price M, Veeramachaneni DN, Parks L (2000): Prenatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci 58(2), 350-65
41. Hoppin JA, Brock JW, Davis BJ, Baird DD (2002): Reproducibility of urinary phthalate metabolites in first morning urine samples. Environm Health Perspect 110, 515-518
42. Hoyer PB (2001): Reproductive Toxicology: current and future directions. Biochemical Pharmacology. 62, 1557-1564
43. IARC, International Agency for Research on Cancer (2000): Di(2-ethylhexyl)phthalate. In: IARC Monographs 77, 41-148, Lyon
44. Kambia K, Dine T, Gressier B, Germe A-F, Luyckx M, Brunet C, et al. (2001): High-performance liquid chromatographic method for the determination of di(2-ethylhexyl)phthalat in total parenteral nutrition and in plasma. J Chromatogr B 755, 297-303
45. Kavlock R, Boeckelheide K, Chapin R., Cunningham M., Faustman E, Foster P, et al. (2002): NTP Center for the Evaluation of Risks to Human Reproduktion: phthalates expert panel report on the reproductive and developmantel toxicity of di(2-ethylhexyl)phthalate. Reprod Toxicol 16, 529-653
46. Kessler W, Phokha W, Csanady GA und Filser JG (2001): No Background concentrations of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in blood of rats. Arch Toxicol 75, 62-64
47. Koch HM, Gonzalez-Reche LM, Drexler H und Angerer J (2002): Belastung der deutschen Allgemeinbevölkerung mit Diethylhexylphthalat (DEHP) und anderen Phthalaten. 10. Konferenz der Gesellschaft für Hygiene und Umweltmedizin und öffentliches Gesundheitswesen (GHU) und 6. Konferenz der International Society of Environmental Medicine (ISEM), Greifswald, 25.-27. September, 2002.
48. Koch HM, Gonzalez-Reche LM, Angerer J (2003a): On-line cleanup by multidimensional LC-ESI-MS/MS for high throughput quantification of primary and secondary phthalate metabolites in human urine. J Chromatogr. B 784, 169-182
49. Koch HM, Rossbach B, Dexler H, Angerer J (2003b): Internal exposure of the general population to DEHP and other phthalates - determination of secondary and primary phthalate monoester metabolites in urine. Environ Res, zur Publikation eingereicht
50. Koch HM, Drexler H und Angerer J (2003c): An Estimation of the Daily Intake of Di(2-ethylhexyl)phthalate (DEHP) and Other Phthalates in the General Population. Int J Hyg Environ Health, 206 (2), 77-83
51. Kohn MC, Parham F, Masten SA, Portier CJ, Shelby MD, Brock JW, Needham LL (2000): Human exposure estimates for phthalates. Environ Health Perspect 108, A440-2
52. Kommission der Europäischen Gemeinschaften (1999): Entscheidung der Kommission vom 7. Dezember 1999 über Maβnahmen zur Untersagung des Inverkehrbringens von Spielzeug- und Babyartikeln, die dazu bestimmt sind, von Kindern unter drei Jahren in den Mund genommen zu werden, und aus Weich-PVC bestehen, das einen oder mehrere der Stoffe Diisononylphthalat (DINP); Di-(2-ethyl-hexyl)-phthalat (DEHP), Dibutylphthalat (DBP), Diisodecylphthalat (DIDP), Di-n-octylphthalat (DNOP) oder Benzylbutylphthalat (BBP) enthält, ABl. Nr. L 315, 46
53. Kommission der Europäischen Gemeinschaften (2002): Entscheidung der Kommission vom vom 19. Februar 2002 über eine neunte Verlängerung der Geltungsdauer der Entscheidung 1999/815/EG über Maβnahmen zur Untersagung des Inverkehrbringens von Spielzeugund Babyartikeln, die dazu bestimmt sind, von Kindern unter drei Jahren in den Mund genommen zu werden, und aus Weich-PVC bestehen, das bestimmte Weichmacher enthält. (2002/152/EG) ABl. Nr. L 50, 96-97
54. Leisewitz A. (1999): Endokrine Stoffe. In: Abwassertechnische Vereinigung, Ed: ATV-Schriftenreihe Bd. 15, pp. 22-37. Hennef
55. Lorz PM, Towae FK, Enke W, Jäckh R, Bhargava N (2002): Phthalic acid and derivatives. In: Ullmann's Encyclopedia of Industrial Chemistry. Wiley-VCH, Weinheim
56. MAFF, Departement of Health and the Scottish Executive, Joint Food Safety and Standards Group (1996): Maff UK - Phthalates in food. Food surveillance information Sheet 82, March 1996
57. Meek ME, Chan PKL (1994): Bis(2-ethylhexyl)phthalate: evaluation of risks to health from environmental exposure in Canada. J Environ Sci Health Part C 12, 179-94
58. NTP-CERHR (2000): NTP-CERHR expert panel reports on. Federal Register 65(196), S. 60206 (erhältlich auf der CERHR Website: http://cerhr.niehs.nih.gov)
59. Planck H, Ed (1993): Kunststoffe und und Elastomere in der Medizin. Kohlhammer, Stuttgart
60. Park JD, Habeebu SSM, Klaassen CD (2002): Testicular toxicity of di-(2-ethylhexyl)phthalate in young Sprague-Dawley rats. Toxicology 171, 105-115
61. Peck CC, Zuck TF (1979): DEHP in blood. Transfusion 17, 400-401
62. Peck CC, Albro PW (1982): Toxic potential of the plasticizer di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man. Environ Health Perspect 45, 11-17
63. Pollack GM, Slaughter RL, Buchanan JF, Shen DD (1984): High-performance liquid chromatography procedure for the determination of di(2-ethylhexyl)phthalate in human blood specimens. Problems of variable-extraction yield and the use of standard addition for calibration. J Chromatogr 311, 101-108
64. Poon R, Lecavalier P, Mueller R, Valli VE, Procter BG, Chu I (1997): Subchronic oral toxicity of di-n-octylphthalate and di(2-ethylhexyl)phthalate in the rat. Food Chem Toxicol 35, 225-239
65. Purdham J, Sass-Kortsak A, Bozek P, Ellis S (1999): Feasibility study on the use of 2-ethylhexanol as a biological indicator of di(2-ethylhexyl)phthalate exposure. AIHCE American Industrial Hygiene Conference & Exposition, June 5 - 11, 1999, Metro Toronto Convention Centre, Toronto, Ontario, Canada
66. Rippen G (2000): Di(2-ethylhexyl)phthalat. In: Handbuch Umweltchemikalien. 51. Ergänzungslieferung. Ecomed, Landsberg
67. Sampson EJ, Needham LL, Pirkle JL, Hannon WH, Miller DT, Patterson DG, et al. (1994): Technical and scientific developments in exposure marker methodology. Clin Chem 40, 1376-1384
68. Schmid P, Schlatter C (1985): Excretion and metabolism of di(2-ethylhexyl)phthalate in man. Xenobiotica 15, 251-256
69. Silva MJ, Malek NA, Kato K, Brock JW, Barr DB, Needham LL, Calafat AM (2002): Assessing human exposure to phthalates. 14th Annual Conference of the International Society for Environmental Epidemiology and 12th Annual Conference of the International Society of Exposure Analysis. 11-15. August 2002, Vancouver, Canada.
70. Sjöberg P, Bondesson U (1985): Determination of di(2-ethylhexyl)-phthalate and four of its metabolites in blood plasma by gas chromatography - mass spectrometry. J Chromatogr 344, 167-175
71. Sjöberg P, Bondesson U, Sedin G, Gustafsson J (1985): Disposition of di- and mono-(2-ethylhexyl)phthalate in newborn infants subjected to exchange transfusions. Eur J Clin Invest 15, 430-436
72. Wahl HG, Hofmann A, Luft D, Liebich HM (1999). Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A 847, 117-125
73. Wahl HG, Hong Q, Stübe D, Meier ME, Häring H-U, Liebich HM (2001): Simultaneous analysis of the di(2-ethylhexyl)phthalate metabolites 2-ethylhexanoic acid, 2-ethyl-3-hydroxyhexanoic acid and 2-ethyl-3-oxohexanoic acid in urine by gas chromatography-mass spectrometry. J Chromatogr B 758, 213-219